Amplification and overexpression of the MDM4 (MDMX) gene from 1q32 in a subset of malignant gliomas without TP53 mutation or MDM2 amplification

Cancer Research

Volumn 59, Issue 24, 1999, Pages 6091-6096

  Riemenschneider, Markus J ^a   Büschges, Rainer ^a   Wolter, Marietta ^a   Reifenberger, Julia ^b   Boström, Jan ^a   Kraus, Jürgen A ^a   Schlegel, Uwe ^a   Reifenberger, Guido ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ARTICLE; CHROMOSOME 1Q; GENE AMPLIFICATION; GENE MUTATION; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTO ONCOGENE;

CELL DIVISION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 1; GENE AMPLIFICATION; GLIOMA; HUMANS; MUTATION; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0343819885     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rasheed, B. K., Wiltshire, R. N., Bigner, S. H., and Bigner, D. D. Molecular pathogenesis of malignant gliomas. Curr. Opin. Oncol., 11: 162-167, 1999.
2. Collins, V. P. Progression as exemplified by human astrocytic tumors. Semin. Cancer Biol., 9: 267-276, 1999.
3. Fulci, G., Ishii, N., and van Meir, E. G. p53 and brain tumors: from gene mutations to gene therapy. Brain Pathol., 8: 599-613, 1998.
4. Reifenberger, J., Reifenberger, G., Liu, L., James, C. D., Wechsler, W., and Collins, V. P. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p. Am. J. Pathol., 145: 1175-1190, 1994.
5. Kros, J. M., van Run, P. R., Alers, J. C., Beverloo, H. B., van den Bent, M. J., Avezaat, C. J., and van Dekken, H. Genetic aberrations in oligodendroglial tumours: an analysis using comparative genomic hybridization (CGH). J. Pathol., 188: 282-288, 1999.
6. Bigner, S. H., Matthews, M. R., Rasheed, B. K., Wiltshire, R. N., Friedman, H. S., Friedman, A. H., Stenzel, T. T., Daw s, D. M., McLendon, R. E., and Bigner, D. D. Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization. Am. J. Pathol., 155: 375-386, 1999.
7. INK4a, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene, 13: 1065-1072, 1996.
8. Ueki, K., Ono, Y., Henson, J. W., Efird, J. T., von Deimling, A., and Louis, D. N. CDKN2/P16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res., 56: 150-153, 1996.
9. Costello, J. F., Plass, C., Arap, W., Chapman, V. M., Held, W. A., Berger, M. S., Su Huang, H. J., and Cavenee, W. K. Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA. Cancer Res., 57: 1250-1254, 1997.
10. Büschges, R., Weber, R. G., Actor, B., Lichter, P., Collins, V. P., and Reifenberger, G. Amplification and expression of cyclin D genes (CCND1, CCND2 and CCND3) in human malignant gliomas. Brain Pathol., 9: 435-442, 1999.
11. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E. E., and Collins, V. P. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53: 2736-2739, 1993.
12. Ishii, N., Maier, D., Merlo, A., Tada, M., Sawamura, Y., Diserens, A. C., and van Meir, E. G. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol., 9: 469-479, 1999.
13. Shvarts, A., Steegenga, W. T., Riteco, N., van Laar, T., Dekker, P., Bazuine, M., van Ham, R. C. A., van der Houven van Oordt, W., Hateboer, G., van der Eb, A. J., and Jochemsen, A. G. MDMX: a novel p53-binding protein with some functional properties of MDM2. EMBO J., 15: 5349-5357, 1996.
14. Shvarts, A., Bazuine, M., Dekker, P., Ramos, Y. F. M., Steegenga, W. T., Merckx, G., van Ham, R. C. A., van der Houven van Oordt, W., van der Eb, A. J., and Jochemsen, A. G. Isolation and identification of the human homolog of a new p53-binding protein. Mdmx. Genomics, 43: 34-42, 1997.
15. Tanimura, S., Ohtsuka, S., Mitsui, K., Shirouzu, K., Yoshimura, A., and Ohtsubo, M. MDM2 interacts with MDMX through their RING finger domains. FEBS Lett., 447: 5-9, 1999.
16. Muleris, M., Almeida, A., Dutrillaux, A. M., Pruchon, E., Vega, F., Delattre, J. Y., Poisson, M., Malfoy, B., and Dutrillaux, B. Oncogene amplification in human gliomas: a molecular cytogenetic analysis. Oncogene 9: 2717-2722, 1994.
17. Schröck, E., Thiel, G., Lozanova, T., du Manoir, S., Meffert, M. C., Jauch, A., Speicher, M. R., Nürnberg, P., Vogel, S., Jänisch, W., Donis-Keller, H., Ried, T., Witkowski, R., and Cremer, T. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses. Am. J. Pathol., 144: 1203-1218, 1994.
18. Almeida, A., Zhu, X. X., Vogt, N., Tyagi, R., Muleris, M., Dutrillaux, A. M., Dutrillaux, B., Ross, D., Malfoy, B., and Hanash, S. GAC1, a new member of the leucine-rich repeat superfamily on chromosome band 1q32.1, is amplified and overexpressed in malignant gliomas. Oncogene 16: 2997-3002, 1998.
19. Kleihues, P., Burger, P. C., and Scheithauer, B. Histological Typing of Tumours of the Central Nervous System, pp. 16-19. Berlin: Springer-Verlag, 1993.
20. Cobbers, J. M. J. L., Wolter, M., Reifenberger, J., Ring, G. U., Jessen, F., An, H. X., Niederacher, D., Schmidt, E. E., Ichimura, K., Floeth, F., Kirsch, L., Borchard, F., Louis, D. N., Collins, V. P., and Reifenberger, G. Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSL. Brain Pathol., 8: 263-276, 1998.
21. Reifenberger, J., Ring, G. U., Gies, U., Cobbers, J. M. J. L., Oberstraß, J., An, H. X., Niederacher, D., Wechsler, W., and Reifenberger, G. Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J. Neuropathol. Exp. Neurol., 55: 822-831, 1996.
22. Rallapalli, R., Strachan, G., Cho, B., Mercer, W. E., and Hall, D. J. A novel MDMX transcript expressed in a variety of transformed cell lines encodes a truncated protein with potent p53 repressive activity. J. Biol. Chem., 274: 8299-8308, 1999.
23. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
24. Freedman, D. A., Wu, L., and Levine, A. J. Functions of the MDM2 oncoprotein. Cell. Mol. Life Sci., 55: 96-107, 1999.
25. Momand, J., Jung, D., Wilczynski, S., and Niland, J. The MDM2 gene amplification database. Nucleic Acids Res., 26: 3453-3459, 1998.
26. Ariza, A., Fernandez, L. A., Inagami, T., Kim, J. H., and Manuelidis, E. E. Renin in glioblastoma multiforme and its role in neovascularization. Am. J. Clin. Pathol., 90: 437-441, 1988.
27. Steffens, J., Bock, R., Braedel, H. U., Isenberg, E., Buhrle, C. P., and Ziegler, M. Renin-producing renal cell carcinomas - clinical and experimental investigations on a special form of renal hypertension. Urol. Res., 20: 111-115, 1992.
28. Kew, M. C., Leckie, B. J., and Greeff, M. C. Arterial hypertension as a paraneoplastic phenomenon in hepatocellular carcinoma. Arch. Intern. Med., 149: 2111-2113, 1989.
29. Saijo, M., Sakai, Y., Kishino, T., Niikawa, N., Matsuura, Y., Morino, K., Tamai, K., and Taya, Y. Molecular cloning of a human protein that binds to the retinoblastoma protein and chromosomal mapping. Genomics, 27: 511-519, 1995.
30. Woitach, J. T., Zhang, M., Niu, C. H., and Thorgeirsson, S. S. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability. Nat. Genet., 19: 371-374, 1998.
31. Tymms, M. J., Ng, A. Y. N., Thomas, R. S., Schutte, B. C., Zhou, J., Eyre, H. J., Sutherland, G. R., Seth, A., Rosenberg, M., Papas, T., Debouck, C., and Kola, I. A novel epithelial-expressed ETS gene, ELF3: human and murine cDNA sequences, murine genomic organization, human mapping to 1q32.2 and expression in tissues and cancer. Oncogene, 15: 2449-2462, 1997.
32. Giovane, A., Sobieszcvuk, P., Mignon, C., Mattel, M. G., and Wasylyk, B. Locations of the ets subfamily members net, elkI, and sap1 (ELK3, ELK1, and ELK4) on three homologous regions of the mouse and human genomes. Genomics, 29: 769-772, 1995.
33. Zanke, B., Squire, J., Griesser, H., Henry, M., Suzuki, H., Patterson, B., Minden, M., and Mak, T. W. A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1 Leukemia, 8: 236-244, 1994.
34. Knuutila, S., Bjorkqvist, A. M., Autio, K., Tarkkanen, M., Wolf, M., Monni, O., Szymanska, J., Larramendy, M. L., Tapper, J., Pere, H., El-Rifai, W., Hemmer, S., Wasenius, V. M., Vidgren, V., and Zhu, Y. DNA copy number amplifications in human neoplasms: review of comparative genomic hybridization studies. Am. J. Pathol., 152: 1107-1123, 1998.